drugset / Trial / NCT02447705

Replacement of Lamivudine by Telbivudine to Improve Renal Function

NCT02447705

Phase 2/3 Completed 120 enrolled Chang Gung Memorial Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Nephrotoxicity is one of the adverse effects of lamivudine and dosage of lamivudine has to be reduced if patients' renal function is insufficiency. Telbivudine may improve glomerular filtration rate. This study is to see whether renal function is improved when Lamivudine is replaced by telbivudine in liver transplantation patients.

Timeline

Start
2013-06
Primary completion
2016-12-31
Completion
2017-01-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Telbivudine Small molecule